Pricing Log in Create free account

Clearmind Medicine Inc. (CMND) vs Ernexa Therapeutics Inc. (ERNA)

Clearmind Medicine Inc. and Ernexa Therapeutics Inc. are both Biotechnology companies. Clearmind Medicine Inc. and Ernexa Therapeutics Inc. are of similar size ($3.0M and $3.0M). Across the 10 metrics below, Ernexa Therapeutics Inc. leads on 6 and Clearmind Medicine Inc. on 4.

Valuation

Metric CMND ERNA Biotechnology median
P/E n/m n/m 10.60
P/S n/m 3.82 9.40
P/B 0.08 0.70 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 1.48 n/m 0.66
EV/Sales n/m 50.76 9.02
Earnings yield (13,692.68%) (992.55%) (32.88%)
Free cash flow yield (661.85%) (399.18%) (23.13%)

Profitability

Metric CMND ERNA Biotechnology median
Gross margin 0.00% 83.51% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (106.98%) (321.22%) (51.96%)
Return on assets (71.81%) (176.62%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CMND ERNA Biotechnology median
Revenue growth (TTM) — (78.60%) 6.76%
EPS growth (last fiscal year) 55.10% 95.42% 29.88%
Revenue growth, 5-year CAGR — (52.20%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CMND ERNA Biotechnology median
Debt to equity 0.13 0.00 0.00
Current ratio 4.31 2.01 4.97
Net debt to EBITDA 0.68 0.21 1.01

Dividend

Metric CMND ERNA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CMND ERNA Biotechnology median
Market cap 2.96m 2.99m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack